Publications by authors named "Tasuku Yajima"

Article Synopsis
  • Dural arteriovenous fistula (dAVF) is typically treated with endovascular therapy, but this method has risks like embolic material migration and brain infarction.* -
  • A case involving a man with left hemiparesis revealed a successfully treated dAVF, but also resulted in complications such as subarachnoid hemorrhage post-treatment.* -
  • The case emphasizes the importance of careful preoperative assessments and thorough postoperative monitoring in managing dAVF, with a need for more research on unexplained complications.*
View Article and Find Full Text PDF

Background: Idarucizumab is a specific antidote for the anticoagulant dabigatran. Although its efficacy has been recently reported, the drug is still in postmarketing surveillance and requires case data in different emergency settings. A newer intravenous thrombolytic therapy with recombinant tissue plasminogen activator has been proposed after injection of idarucizumab in patients receiving dabigatran; however, the safety and efficacy of this therapy are equivocal because of the limited number of reported cases.

View Article and Find Full Text PDF